Cetera Investment Advisers
LGND icon

Cetera Investment Advisers’s Ligand Pharmaceuticals LGND Stock Holding History

Cetera Investment Advisers’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Sell
3,738
-521
-12% -$123K ﹤0.01% 2886
2026
Q1 		$850K Buy
4,259
+924
+28% +$183K ﹤0.01% 3044
2025
Q4 		$631K Buy
3,335
+1,759
+112% +$338K ﹤0.01% 3238
2025
Q3 		$279K Buy
+1,576
New +$234K ﹤0.01% 3888

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cetera Investment Advisers's LGND Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Ligand Pharmaceuticals (LGND) stake by 12% in Q2 2026, selling an estimated $123K and leaving 3,738 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2886.

Cetera Investment Advisers first reported a position in LGND in Q3 2025 and has held it in 4 quarters since. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Cetera Investment Advisers held 3,738 shares of Ligand Pharmaceuticals worth $1.18M as of Q2 2026.
  • Cetera Investment Advisers sold 521 Ligand Pharmaceuticals shares in Q2 2026, an estimated $123K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2886 holding.
  • Cetera Investment Advisers first reported a position in Ligand Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.